Vista is a preeminent technology investor, specializing in enterprise AI and software, with over $100 billion in AUM. For over 25 years and across every technology cycle, Vista has been pioneering new approaches to software investing, delivering consistent and compelling results at scale. Today, we're applying that expertise to help harness the transformative potential of AI to redefine how work gets done. Further information is available atvistaequitypartners.com.
The information included on this page is for informational purposes only. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of Vista or any Vista-managed fund. Additional disclosures can be found here: https://www.vistaequitypartners.com/disclosures/.
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Our areas of expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research.